- Home
- FR vs PCVX Comparison
FR vs PCVX Comparison
Compare FR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FR | PCVX |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 6.1B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FR | PCVX |
|---|---|---|
| Price | $58.89 | $45.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | $57.64 | ★ $105.00 |
| AVG Volume (30 Days) | 910.6K | ★ 1.3M |
| Earning Date | 02-04-2026 | 02-24-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | ★ $714,032,000.00 | N/A |
| Revenue This Year | $10.87 | N/A |
| Revenue Next Year | $7.46 | N/A |
| P/E Ratio | $32.61 | ★ N/A |
| Revenue Growth | ★ 8.93 | N/A |
| 52 Week Low | $40.31 | $27.66 |
| 52 Week High | $59.43 | $93.77 |
Technical Indicators
Market Signals| Indicator | FR | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 59.63 | 48.85 |
| Support Level | $57.28 | $43.95 |
| Resistance Level | $59.36 | $47.55 |
| Average True Range (ATR) | 0.90 | 1.87 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 85.40 | 49.93 |
Price Performance
Historical ComparisonAbout FR First Industrial Realty Trust Inc.
First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.